National Institute on Drug Abuse Center for Genetic Studies

On September 19, 2018, the National Institute on Drug Abuse (NIDA) finalized an award for the National Institute on Drug Abuse Center for Genetic Studies under solicitation number NIHDA201800084. The contract was issued to Rutgers, The State University of New Jersey, located in New Brunswick, New Jersey. This award establishes an indefinite delivery, indefinite quantity contract with a four-year ordering period and a total potential value not to exceed $19,700,000.

The scope of this requirement falls under NAICS code 541714 for Research and Development in Biotechnology (except Nanobiotechnology) and PSC code A. At the time of the base contract award, NIDA issued the initial task order, HHSN27100001, in the amount of $1,647,593. While the government anticipates the use of fixed-price task orders that are fully funded upon issuance, the total obligated amount across the contract vehicle is subject to the established $19,700,000 ceiling.

This notice of award serves as the formal conclusion to the Request for Proposal process for NIDA Reference Number N01DA-18-7797. Joshua T. Lazarus is the designated point of contact for this action, which was officially published on October 5, 2018. No set-aside was utilized for this procurement.